AT2 Receptor Agonists: Exploiting the Beneficial Arm of Ang II Signaling

E-ISSN： 1875-6506|8|1|47-59

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.8, Iss.1, 2012-02, pp. : 47-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AngII residues in the regulation of receptor activity

By Olivares-Reyes J.A. Hernandez-Aranda J.

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 5, 2002-07 ,pp. : 188-188

Elsevier

Access to resources Recommend Favorite

Protease-Activated Receptor-2 Antagonists and Agonists

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 1, 2003-03 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan Protects Against Neurological Deficits and Prolongs Survival in Spontaneously Hypertensive Rats Stroke-Prone (SHR-SP) Infused with Ang II

Vascular Disease Prevention, Vol. 4, Iss. 2, 2007-05 ,pp. : 151-154

Bentham Science Publishers

Access to resources Recommend Favorite

Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth

By Horiuchi M. Lehtonen J.Y.A. Daviet L.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 10, 1999-12 ,pp. : 391-396

Elsevier

Access to resources Recommend Favorite

GLP-1 receptor agonists in the treatment of Type 2 diabetes

By Ahrén Bo

Diabetes Management, Vol. 3, Iss. 5, 2013-09 ,pp. : 401-413

Future Medicine

Access to resources Recommend Favorite